Employer record · South San Francisco, CA · FY2023–FY2026

Lyterian Therapeutics

    Certified LCAs
    6
    FY2024–FY2026
    USCIS approvals
    2
    2 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $150k
    certified LCAs

    Jobs not indexed yet

    Does Lyterian Therapeutics sponsor H-1B visas?

    Yes — by its record, Lyterian Therapeutics is a small-scale H-1B sponsor: it filed 6 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 2 USCIS H-1B petition approvals (2 for new employment). Its latest certified LCA in our data was decided Sep 8, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 9 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Lyterian Therapeutics certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2331100%
    FY2422100%
    FY2530–
    FY2610–

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Biochemists and Biophysicists 19-10213$157k
    Bioengineers and Biomedical Engineers 17-20311$100k
    Medical Scientists, Except Epidemiologists 19-10421$143k
    Chemists 19-20311$281k

    Most-filed job titles

    1. Scientist I3$143k
    2. Executive Director, Early Lead Chemistry1$281k
    3. Principal Scientist1$157k
    4. Senior Research Associate1$100k

    LCAs per title and median wage offered.

    Where the jobs were

    1. California6 LCAs

    We haven't indexed Lyterian Therapeutics' jobs yet

    We read jobs straight from employers' own career sites and haven't added Lyterian Therapeutics' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • Lyterian Therapeutics (LCA)
    • LYTERIAN THERAPEUTICS INC (USCIS)

    Lyterian Therapeutics H-1B: questions people ask

    Does Lyterian Therapeutics sponsor H-1B visas?

    Yes — by its record, Lyterian Therapeutics is a small-scale H-1B sponsor: it filed 6 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 2 USCIS H-1B petition approvals (2 for new employment). Its latest certified LCA in our data was decided Sep 8, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Lyterian Therapeutics still sponsoring H-1B in 2026?

    Lyterian Therapeutics had 1 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 3 in FY2025. The latest one in our data was decided Sep 8, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Lyterian Therapeutics get approved?

    USCIS recorded 2 approvals (2 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Lyterian Therapeutics in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Lyterian Therapeutics?

    The median wage offered on Lyterian Therapeutics's certified LCAs in FY2024–FY2026 was $150k a year. By job title: Scientist I $143k (3 LCAs), Executive Director, Early Lead Chemistry $281k (1 LCAs) and Principal Scientist $157k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Lyterian Therapeutics sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Biochemists and Biophysicists (3), Bioengineers and Biomedical Engineers (1) and Medical Scientists, Except Epidemiologists (1).

    Where are Lyterian Therapeutics's H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): California (6).

    Is Lyterian Therapeutics an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Lyterian Therapeutics have open jobs?

    We read jobs straight from employers' own career sites and haven't added Lyterian Therapeutics' yet.